Volume 122, Issue 2 , Pages 274-279, August 2008
Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy
Background
Cesarean delivery can alter neonatal immune responses and increase the risk of atopy. Studies of the relation between cesarean delivery and allergic diseases in children not selected on the basis of a family history of atopy have yielded inconsistent findings.
Objective
We sought to examine the relation between birth by cesarean delivery and atopy and allergic diseases in children at risk for atopy.
Methods
We examined the relation between mode of delivery and the development of atopy and allergic diseases among 432 children with a parental history of atopy followed from birth to age 9 years. Asthma was defined as physician-diagnosed asthma and wheeze in the previous year, and allergic rhinitis was defined as physician-diagnosed allergic rhinitis and naso-ocular symptoms apart from colds in the previous year. Atopy was considered present at school age if there was 1 or more positive skin test response or specific IgE to common allergens. Stepwise logistic regression was used to study the relation between cesarean delivery and the outcomes of interest.
Results
After adjustment for other covariates, children born by cesarean section had 2-fold higher odds of atopy than those born by vaginal delivery (odds ratio, 2.1; 95% CI, 1.1-3.9). In multivariate analyses birth by cesarean section was significantly associated with increased odds of allergic rhinitis (odds ratio, 1.8; 95% CI, 1.0-3.1) but not with asthma.
Conclusions
Our findings suggest that cesarean delivery is associated with allergic rhinitis and atopy among children with a parental history of asthma or allergies. This could be explained by lack of contact with the maternal vaginal/fecal flora or reduced/absent labor during cesarean delivery.
Key words: Cesarean delivery, allergic rhinitis, atopy, childhood
Abbreviation used: OR, Odds ratio
Supported by grant AI/EHS35786 from the National Institutes of Health to Dr Gold. Dr Celedón is supported by grants HL66289, HL079966, and HL073373 from the National Institutes of Health.
Disclosure of potential conflict of interest: M. Pistiner has received research support from the National Institutes of Health (NIH). D. R. Gold has been a guest speaker for Indoor Biotechnologies and has received research support from NIH and the UN Environmental Protection Agency. J. C. Celedón has received research support from NIH. The rest of the authors have declared that they have no conflict of interest.
PII: S0091-6749(08)00940-8
doi:10.1016/j.jaci.2008.05.007
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 122, Issue 2 , Pages 274-279, August 2008
